Newsstand Menu

Home / Newsstand / CSHL Stories and Media

CSHL Stories and Media archive for Tag: technology transfer

Filter by tag

New incubator model for CSHL spin-outs

6/7/2021

When a CSHL lab discovers a potential drug target, Autobahn Labs will collaborate with us to direct CRO work at Evotec funded by Samsara BioCapital. Read the story »

$11 million investment to develop fibroblast therapeutic

4/26/2021

CSHL Professor David Tuveson and other leading disease experts founded a company to target fibroblasts as a new way to treat cancer and inflammatory diseases. Read the story »

Cold Spring Harbor Laboratory announces exclusive license with plant breeding start-up Inari

4/16/2019

CSHL announced a licensing agreement with partner Inari, a company that is advancing plant breeding by tapping nature’s genetic diversity. Read the story »

Breakthrough Prize laureates meet at CSHL

12/6/2018

Breakthrough Prize winner Adrian Krainer & C. Frank Bennett reunite for the first time since their award ceremony at CSHL to discuss further project. Read the story »

The case for open and inclusive science

6/8/2018

America must continue to a place where the most talented people in the world want to live, study and work. Read the story »

Andrew Whiteley appointed VP of Business Development and Technology Transfer at CSHL

4/3/2018

Life science business leader Andrew Whiteley becomes the Vice President of CSHL's Business Development and Technology Transfer department. Read the story »

Library of CRISPR targeting sequences increases power and accuracy of the gene-editing method

7/20/2017

New library of RNA sequences that can be used by researchers to direct the CRISPR-cas9 complex to cut DNA with unprecedented precision. Read the story »

Executive in Residence to mentor scientific entrepreneurs at Cold Spring Harbor Laboratory

4/15/2016

Andrew Whiteley joined the Cold Spring Harbor Laboratory Office of Technology Transfer as the first Executive in Residence. Read the story »

Cold Spring Harbor Laboratory engages Hairpin Technologies Inc. to license its short hairpin RNA (shRNA) technology

3/31/2015

Cold Spring Harbor Laboratory engaged Hairpin Technologies Inc. to expand the commercial distribution and research use of short hairpin RNA. Read the story »

Cold Spring Harbor Laboratory and GSK to develop diabetes and obesity therapeutic

3/23/2015

CSHL announced a collaboration with GSK to develop a treatment for obesity and type 2 diabetes. Read the story »

Mechanistic insights into spinal muscular atrophy suggest new paths for treatment

1/12/2015

Researchers find that in mouse models of the disease subcutaneous drug administration is sufficient to treat SMA Read the story »

Cold Spring Harbor Laboratory announces settlement in patent malpractice case against Ropes & Gray

6/2/2014

CSHL ramps up licensing of its short-hairpin RNA technology already used widely in cancer research and drug development Read the story »

Ohr Pharmaceutical and CSHL announce joint venture to develop trodusquemine and related analogs

3/3/2014

Ohr Pharmaceutical and CSHL announce a new joint venture to develop trodusquemine and related analogs. Read the story »

Teri F. Willey VP Business Development and Technology Transfer

Cold Spring Harbor Laboratory appoints Teri F. Willey to accelerate commercialization efforts

9/6/2013

As VP of Business Development & Technology Transfer, Willey will build on strong record of success in venture capital and research commercialization Read the story »

RNA Interference Library covers entire human genome

3/24/2004

CSHL scientists created the first library of human RNA interference clones. Read the story »